Changeflow GovPing Healthcare & Life Sciences USPTO Patent Application: Topical Delivery Systems
Routine Notice Added Final

USPTO Patent Application: Topical Delivery Systems

Email

Summary

The USPTO has published a new patent application (US20260083647A1) detailing topical delivery systems and multi-phase formulations. The application describes sustained-release barrier formulations designed for skin application, potentially offering time-dependent effects like hair follicle softening and delayed active ingredient delivery.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a USPTO patent application (US20260083647A1) for topical delivery systems and multi-phase formulations. It describes a method for creating a sustained-release moisturizing barrier for skin application by combining multi-phase ingredients into emulsified systems. The patent claims features such as multivesicular and/or multi-lamellar characteristics that provide time-dependent effects, including hair follicle softening and delayed active ingredient delivery.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future innovation and intellectual property in the pharmaceutical and cosmetic sectors. Companies involved in drug delivery systems, skincare, and cosmetic product development should be aware of this filing as it may impact future product development and market exclusivity in these areas.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

TOPICAL DELIVERY SYSTEMS AND METHODS OF USE

Application US20260083647A1 Kind: A1 Mar 26, 2026

Inventors

Roger H. Tall

Abstract

Topical delivery systems, multi-phase topical application formulations, and methods of use including combining multi-phase ingredients to form a first emulsified system, such as a pre-mixture hydrogel. A second emulsified system is formed to be combined with the pre-mixture hydrogel to form an emulsified topical application formulation. Additives and/or adjuvants are combined with the emulsified multi-phase formulation to form a delivery system. Delivery systems include a combined sustained-release, moisturizing barrier which may be applied to the skin. Multivesicular and/or multi-lamellar characteristics of the barrier provide for time-dependent effects, such as hair follicle softening and/or delayed active ingredient delivery.

CPC Classifications

A61K 8/066 A61Q 9/02 A61K 2800/594 A61K 2800/596

Filing Date

2025-09-25

Application No.

19339315

View original document →

Named provisions

Topical Delivery Systems and Methods of Use

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083647A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Delivery Systems Cosmetic Formulation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Product Development Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!